Comparison of intravitreal injection of ranibizumab versus bevacizumab for treatment of type 1 and aggressive retinopathy of prematurity in rural Egypt. A randomized clinical trial

OBJECTIVE: The objective of this study is to evaluate the efficacy of intravitreal ranibizumab (IVR) monotherapy compared with intravitreal bevacizumab (IVB) monotherapy for treatment of type 1 and aggressive retinopathy of prematurity (ROP) in rural Egypt. METHODS: 36 eyes of 18 infants with bilate...

Descripción completa

Detalles Bibliográficos
Autores principales: Tawfik, Ghada Mahmoud, Shahein, Ezzat A, Dabour, Sherif A, Hassanein, Dina, Elshewy, Ahmed Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Retina
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809260/
http://dx.doi.org/10.1136/bmjophth-2022-001173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809260/
http://dx.doi.org/10.1136/bmjophth-2022-001173

Ejemplares similares